Skip to main content

Anna Meseguer Navarro

Institutions of which they are part

Head of group
Kidney Physiopathology
Vall Hebron Institut de Recerca

Anna Meseguer Navarro

Institutions of which they are part

Head of group
Kidney Physiopathology
Vall Hebron Institut de Recerca

Projects

Red de investigación Renal

IP: Daniel Serón Micas
Collaborators: Joan López Hellin, Anna Meseguer Navarro, Francesc Moreso Mateos, Enric Trilla Herrera, Natalia Ramos Terrades, Joana Sellarés Roig, Maria Teresa Salcedo Allende, Concepció Jacobs Cachá, Manel Perelló Carrascosa
Funding agency: Instituto de Salud Carlos III
Funding: 92250
Reference: RD12/0021/0013
Duration: 01/01/2013 - 31/12/2016

Biomarcadores diagnósticos y pronósticos de recidiva de glomerulonefritis segmentaria y focal en trasplante de riñón

IP: Joan López Hellin
Collaborators: Anna Meseguer Navarro, Daniel Serón Micas, Paula Fernández Álvarez
Funding agency: Fundación Invest. Médica Mutua Madrileña
Funding: 20000
Reference: FMM-2011-08
Duration: 28/07/2011 - 27/07/2012

Kidney and sex hormones: Novel insights into development and progression of the metabolic syndrome

IP: Anna Meseguer Navarro
Collaborators: Joan López Hellin, Concepció Jacobs Cachá, Andrea Caballero Garralda
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 266200
Reference: SAF2011-29506
Duration: 01/01/2012 - 31/12/2014

Ministerio de Ciencia

Role of the kidney androgen-regulated protein (KAP) as a mediator of the cardiometabolic syndrome

IP: Anna Meseguer Navarro
Collaborators: -
Funding agency: Fundación Renal Iñigo Alvarez de Toledo
Funding: 9000
Reference: FRIAT-2009-01
Duration: 01/01/2010 - 31/12/2010

Related news

The communication is part of a study aimed at identifying the mechanisms of progression of Familial Hypomagnesemia with Hypercalciuria and Nephrocalcinosis, a rare disease that affects the kidneys.

"Patients with familial hypomagnesemia with hypercalciuria and nephrocalcinosis present miRNA profiles in urinary extracellular vesicles associated with disease progression" was the awarded work.

Researchers at the VHIR have carried out a study showing that the ClC-5 protein regulates collagen levels through the β-catenin pathway and lysosomal degradation.

Related professionals

Pablo Sanchez Sancho

Pablo Sanchez Sancho

Research technician
Basic, Translational and Clinical Pharmacy Research
Read more
Cristopher Alan Mazo Torre

Cristopher Alan Mazo Torre

Postdoctoral researcher
Clinical Research/Innovation in Pneumonia & Sepsis (CRIPS)
Read more
Patricia Bogdanov Baruj

Patricia Bogdanov Baruj

Postdoctoral researcher
Diabetes and Metabolism
Read more
Daniel Sánchez-Tejerin San José

Daniel Sánchez-Tejerin San José

Predoctoral researcher
Peripheral Nervous System
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.